发明名称 GLUCAGON-LIKE PEPTIDE 1 (GLP-1) PHARMACEUTICAL FORMULATIONS
摘要 A composition is disclosed comprising glucagon-like peptide 1 (GLP-1) particles in combination with diketopiperazine (DKP) that is stable both in vitro and in vivo. The composition has utility as a pharmaceutical formulation for treating diseases such as diabetes, cancers, and obesity but is not limited to such diseases or conditions. In particularly, the composition has utility as a pharmaceutical formulation for pulmonary delivery.
申请公布号 US2008260838(A1) 申请公布日期 2008.10.23
申请号 US20070735957 申请日期 2007.04.16
申请人 MANNKIND CORPORATION 发明人 HOKENSON MARK J.;BRANDT DAVID;KING MARK;GREENE STEPHANIE;FARIS MARY;OBERG KEITH;CHEATHAM WAYMAN WENDELL;GELBER COHAVA;LEONE-BAY ANDREA
分类号 A61K9/14;A61K38/16;A61P3/04;A61P3/10;A61P35/00 主分类号 A61K9/14
代理机构 代理人
主权项
地址